US tariffs forced the Brazilian medical devices sector to rethink its entire export strategy.
This segment of the industry ended 2025 exporting US$1.15 billion, an amount 2.83% lower than that recorded in 2024, according to Abimo (Brazilian Association of the Medical Device Industry).
The sector has its main client in the USA, which leads the entity to associate the drop directly with tariffs.
The way out? Get around the tariff barrier by simply avoiding it, looking for other markets.
The USA continued to be the main buyer of Brazilian medical supplies, totaling US$ 289.68 million in the period, growth of 4.61% compared to the previous year. The increase was caused by sales made hastily before the tariff came into force.
However, the increase was even more significant in other markets:
- United Kingdom (+61.19%);
- Türkiye (+52.03%).
- Colombia (+39.46%);
- China (+ 29,75%);
- Germany (+ 28.93%);
- Mexico (+18.69%).
“2025 was a year that tested the resilience of our industry. Even in the face of relevant external barriers, we managed to expand Brazil’s presence in strategic markets and reduce dependence on a few destinations. This diversification movement is fundamental to strengthening the sector’s competitiveness in the long term”, says Larissa Gomes, Projects and Marketing Manager at Abimo.
“We enter 2026 with a clear agenda: to consolidate conquered markets, deepen international relations and increase predictability for companies. We expect progress in the trade dialogue with the United States and the opening of new negotiation fronts. There is room for a more favorable environment for Brazilian exports, and we will work towards this.”
